BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6099011)

  • 1. [Specific mechanism of action of calcium antagonists in the neutralization of experimental coronary spasms].
    Fleckenstein-Grün G; Makita YJ; Byon YK; Frey M
    Z Kardiol; 1984; 73 Suppl 2():71-7. PubMed ID: 6099011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries.
    Godfraind T; Miller RC
    Circ Res; 1983 Feb; 52(2 Pt 2):I81-91. PubMed ID: 6831654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities.
    Braun LT
    Heart Lung; 1983 May; 12(3):226-32. PubMed ID: 6551368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History of calcium antagonists.
    Fleckenstein A
    Circ Res; 1983 Feb; 52(2 Pt 2):I3-16. PubMed ID: 6339106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of the relaxant action of noradrenaline on coronary artery smooth muscle cells].
    Nikitina EI; Kochemasova NG; Taranenko VM; Shuba MF
    Biull Eksp Biol Med; 1981 May; 91(5):517-20. PubMed ID: 6266555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonists in the treatment of coronary heart disease].
    Rafflenbeul W
    Fortschr Med; 1984 Jul; 102(27-28):718-21. PubMed ID: 6479814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockers.
    Deedwania PC
    West J Med; 1982 Jul; 137(1):24-31. PubMed ID: 6291255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanisms of the direct action of etomidate on vascular reactivity in rat mesenteric resistance arteries.
    Shirozu K; Akata T; Yoshino J; Setoguchi H; Morikawa K; Hoka S
    Anesth Analg; 2009 Feb; 108(2):496-507. PubMed ID: 19151278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonists: sites of action, pharmacological effect profile and clinical use. 1: Physiologic significance of calcium ions and mechanisms of action of calcium antagonists in the subcellular area].
    Bluth R; Langnickel R
    Z Arztl Fortbild (Jena); 1986; 80(5):191-7. PubMed ID: 2424181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of drugs on the upper urinary tract of the human].
    Hertle L; Nawrath H
    Urologe A; 1986 Sep; 25(5):252-8. PubMed ID: 2431530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity of calcium antagonistic action in vascular smooth muscle.
    van Breemen C; Mangel A; Fahim M; Meisheri K
    Am J Cardiol; 1982 Feb; 49(3):507-10. PubMed ID: 6277176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine sensitization of coronary artery contractions: mechanism of drug-induced spasm.
    Kalsner S
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1132-40. PubMed ID: 7680716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular aspects of calcium antagonists.
    Van Zwieten PA; Van Meel JC; Timmermans PB
    Pharm Weekbl Sci; 1981 Dec; 3(6):237-47. PubMed ID: 6120500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonists. Some chemical-pharmacologic aspects.
    Triggle DJ; Swamy VC
    Circ Res; 1983 Feb; 52(2 Pt 2):I17-28. PubMed ID: 6299605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of manganese and verapamil on electrical and contractile responses of pulmonary artery smooth muscle induced by noradrenaline and histamine].
    Gurkovskaia AV
    Biull Eksp Biol Med; 1981 Aug; 92(8):7-9. PubMed ID: 6271297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological analysis of a disorder in the mechanisms of coronary vessel reactivity in an experimental model of coronary insufficiency].
    Lysenko LT; Trubetskoĭ AV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(2):74-82. PubMed ID: 7317162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.